A signature of plasma exosomal miRNAs predict therapeutic efficacy to neoadjuvant immunotherapy in patients with non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Zhai W 

PROVIDER: S-EPMC12721357 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature